GeoVax Labs (GOVX) EBIT (QoQ) (2010 - 2025)
GeoVax Labs (GOVX) EBIT (QoQ) (2010 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.71 Bn | 131.86 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.87 Bn | 78.87 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.40 Bn | 60.22 Bn | 1.37 Bn |
| 4 | Moderna | 59.36 Bn | 54.22 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.12 Bn | 37.02 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.91 Bn | 28.60 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.17 Bn | 9.78 Bn | 668.28 Mn |
| 8 | Insmed | 27.58 Bn | 26.42 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - |
| 10 | GeoVax Labs | 2.92 Mn | -220,776.39 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 30.31% |
| Sep 30, 2025 | -17.61% |
| Jun 30, 2025 | -0.25% |
| Mar 31, 2025 | 35.22% |
| Dec 31, 2024 | -42.53% |
| Sep 30, 2024 | -15.65% |
| Jun 30, 2024 | 13.95% |
| Mar 31, 2024 | 23.53% |
| Dec 31, 2023 | 10.54% |
| Sep 30, 2023 | -39.18% |
| Jun 30, 2023 | -44.68% |
| Mar 31, 2023 | 20.73% |
| Dec 31, 2022 | -35.69% |
| Sep 30, 2022 | -77.06% |
| Jun 30, 2022 | 7.64% |
| Mar 31, 2022 | 82.33% |
| Dec 31, 2021 | -604.31% |
| Sep 30, 2021 | -31.26% |
| Jun 30, 2021 | 4.95% |
| Mar 31, 2021 | -16.98% |